This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: I2o Therapeutics, Inc., I20 Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Tyler Brown: Innovator in Metabolic Disease Treatments
Introduction
Tyler Brown is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of pharmaceutical compositions aimed at treating metabolic diseases. With a total of 5 patents to his name, he has made strides in developing innovative therapies for conditions such as diabetes and obesity.
Latest Patents
Among his latest patents, Tyler has developed compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and amylin analogs. These compositions are designed for the treatment of metabolic diseases, including type 1 and type 2 diabetes, obesity, and nonalcoholic steatohepatitis. His work includes detailed formulations that specify the structure of therapeutic agents and their applications in reducing weight in subjects in need.
Career Highlights
Throughout his career, Tyler has worked with notable companies such as I2O Therapeutics, Inc. and I20 Therapeutics, Inc. His expertise in pharmaceutical development has positioned him as a key player in the innovation of treatments for metabolic disorders.
Collaborations
Tyler has collaborated with various professionals in the field, including his coworker Kelly Ibsen, to advance research and development in his area of expertise.
Conclusion
Tyler Brown's innovative work in the pharmaceutical industry continues to pave the way for new treatments for metabolic diseases, showcasing his dedication to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile